The aging study revealed partly overlapping features, with more pronounced glial activation in early stages, driven by MOBP, followed by neuronal deregulation in later stages, driven by GABRB3, the same key driver identified in a large AD coexpression network. Here, GABRB3 is linked to Alzheimer disease.